- You are here:
- Home »
- Blog »
- brain cancer »
- Brain Cancer – Need To Know
Brain Cancer – Need To Know
Brain Cancer – Need To Know: A diagnosis of brain cancer can feel overwhelming. Brain cancer—which includes malignant tumors that grow within the brain or central nervous system—is among the most challenging types of cancer due to its location, complexity, and the critical functions of affected tissue. Understanding the fundamentals of brain cancer, current treatment options, risk factors, symptoms, and strategies to support treatment and survivorship can help patients and caregivers make informed decisions.
If you or someone you love has been diagnosed with brain cancer, understanding the disease, treatment options, and supportive therapies can help you make informed decisions and improve outcomes.
This post explains the essentials of brain cancer and highlights evidence-based integrative therapies that may improve treatment tolerance, immune function, and survivorship.
Be sure to watch each of the videos about:
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about brain cancer.
Good luck,
David Emerson
• Cancer Survivor
• Cancer Coach
• Director PeopleBeatingCancer
What Is Brain Cancer?
Brain cancer refers to malignant (cancerous) tumors that originate in the brain or spread to it from other parts of the body. These tumors are distinct from benign brain tumors in that cancerous cells can invade surrounding brain tissue and, in some cases, spread further.
Brain tumors may be classified broadly as:
- Primary tumors: Tumors that begin within the brain tissue (e.g., glioblastoma, astrocytoma).
- Secondary (metastatic) tumors: Cancers that have spread to the brain from other organs (e.g., lung or breast). Primary brain cancer is much less common than metastatic disease.
Types of Brain Cancer
Some common types include:
- Gliomas – Tumors from glial cells; glioblastoma is the most aggressive type.
- Meningiomas – Often benign but can be malignant and affect brain function.
- Medulloblastomas – More common in children and can be highly aggressive.
- Atypical teratoid rhabdoid tumors (AT/RTs) – Rare, aggressive pediatric tumors.
Brain Cancer by the Numbers
- An estimated 94,390 Americans will receive a primary brain tumor diagnosis in 2023.
- Approximately 28% of brain tumors are malignant (cancer).
- For malignant brain tumors overall, the five-year relative survival is about 35.7%, but this varies widely by tumor type.
- Glioblastoma – the most common malignant primary tumor – has a five-year survival of only about 6.9%, and median survival of roughly 8 months after diagnosis.
These statistics underscore the seriousness of brain cancer but also highlight the importance of ongoing research and innovations in neurosurgery, medical therapy, and supportive care.
Symptoms of Brain Cancer
Symptoms depend on the tumor’s size, location, and growth rate, but common warning signs include:
- Persistent headaches that may worsen over time
- Nausea or vomiting
- Seizures or convulsions
- Changes in speech, vision, or hearing
- Weakness or numbness in limbs
- Balance and coordination problems
- Cognitive or personality changes
Because the brain controls so many basic functions, even small tumors can produce significant symptoms quickly.
Causes and Risk Factors
While the exact cause of most brain cancers is unknown, several factors have been associated with increased risk:
- Exposure to ionizing radiation
- Age (risk increases with age)
- Genetic syndromes (e.g., neurofibromatosis)
- Environmental exposures (some chemical and occupational factors)
Unlike many cancers, lifestyle factors such as diet or smoking are not strongly linked to most primary brain tumors.
Diagnosis
Brain cancer is typically diagnosed using a combination of:
- Neurological exam
- Imaging tests like MRI or CT scans
- Biopsy to confirm tumor type and grade
Tumor grading ranges from WHO Grade I (less aggressive) to Grade IV (most aggressive).
A multi-modal approach (surgery + radiation + chemotherapy) is common for high-grade tumors like glioblastoma, though prognosis remains guarded for aggressive types.
Standard Treatment Overview
Conventional therapy typically includes:
- Surgical resection
- Radiation therapy
- Temozolomide chemotherapy
- Tumor Treating Fields (TTF) in select cases
- Clinical trial participation
Standard of care for glioblastoma is maximal safe resection followed by radiation + temozolomide (Stupp protocol).
Reference: Stupp R, et al. NEJM. 2005.
https://pubmed.ncbi.nlm.nih.gov/15758009/
Integrative & Supportive Therapies for Brain Cancer
Integrative therapies are not replacements for standard treatment. They are evidence-informed approaches used alongside conventional care to:
- Improve treatment tolerance
- Reduce side effects
- Support immune function
- Improve quality of life
Below are therapies with emerging or supportive evidence in neuro-oncology.
1. Nutrition & Metabolic Therapy
Anti-Inflammatory Diet
Dietary patterns rich in:
- Vegetables
- Berries
- Olive oil
- Nuts
- Omega-3 fatty acids
- Lean protein
may reduce systemic inflammation and support overall health.
Reference:
Schwingshackl L, et al. Nutrients. 2018.
https://pubmed.ncbi.nlm.nih.gov/29518923/
Ketogenic / Metabolic Approaches
Glioblastoma cells rely heavily on glucose metabolism. Early studies suggest ketogenic diets may:
- Lower glucose availability
- Increase ketone production
- Potentially enhance sensitivity to radiation or chemotherapy
Evidence remains preliminary but promising.
Reference:
Champ CE, et al. Nutrition & Metabolism. 2014.
https://pubmed.ncbi.nlm.nih.gov/24606868/
Important: Must be supervised medically to avoid weight loss or malnutrition.
2. Exercise Oncology
Exercise in brain tumor patients has been shown to:
- Improve fatigue
- Improve mobility and balance
- Enhance mood
- Preserve muscle mass
Systematic review:
Gehring K, et al. Neuro-Oncology Practice. 2018.
https://pubmed.ncbi.nlm.nih.gov/30288477/
Even light activity (walking, supervised resistance training) can improve functional independence.
3. Mind-Body Therapies
Brain cancer patients often experience anxiety, depression, and cognitive stress.
Evidence supports:
- Mindfulness-Based Stress Reduction (MBSR)
- Gentle yoga
- Guided imagery
- Cognitive behavioral therapy (CBT)
These approaches improve:
- Emotional resilience
- Sleep
- Fatigue
- Quality of life
Reference:
Cillessen L, et al. Psycho-Oncology. 2019.
https://pubmed.ncbi.nlm.nih.gov/30672093/
4. Intravenous Vitamin C (IVC)
High-dose IV vitamin C achieves pharmacologic plasma levels not possible orally.
Proposed mechanisms:
- Pro-oxidant effects in tumor cells
- Enhanced chemotherapy sensitivity
- Reduction in treatment-related fatigue
Early phase trials in glioblastoma show safety and potential synergy with radiation.
Reference:
Ma Y, et al. Redox Biology. 2014.
https://pubmed.ncbi.nlm.nih.gov/24993823/
Important: Should only be administered under supervision of an experienced integrative oncology provider.
Reduce Chemotherapy Side Effects. Studies show high dose vitamin C can help.
5. Gut Microbiome & Brain Cancer
Emerging research suggests:
- The gut microbiome influences immune response
- Microbiome composition may affect immunotherapy outcomes
- Antibiotic exposure may negatively impact treatment response
Reference:
Matson V, et al. Science. 2018.
https://pubmed.ncbi.nlm.nih.gov/29849193/
Supportive strategies include:
- High-fiber plant foods
- Fermented foods
- Avoid unnecessary antibiotics
- Discuss probiotic use with an oncologist
The 5 things you NEED to know for better GUT HEALTH
6. Prehabilitation (Pre-Hab)
Prehabilitation refers to strengthening the patient before surgery or radiation.
Includes:
- Nutritional optimization
- Physical therapy
- Cognitive training
- Stress reduction
- Smoking cessation (if applicable)
Pre-hab improves:
- Surgical recovery
- Functional outcomes
- Post-treatment resilience
Reference:
Silver JK, et al. CA Cancer J Clin. 2013.
https://pubmed.ncbi.nlm.nih.gov/23749692/
In brain tumor patients, preserving baseline function is critical.
Newly Diagnosed with Cancer? How Prehabilitation Prepares You for Treatment
Evidence-Based Supplements for Brain Cancer Patients
Nutritional supplementation should never replace standard therapy, but selected compounds have mechanistic and early clinical evidence suggesting benefit in gliomas and other primary brain tumors.
All supplements should be discussed with your neuro-oncology team before use.
1. Omega-3 Fatty Acids (EPA/DHA)
Why They Matter
Omega-3 fatty acids (EPA and DHA):
- Reduce neuroinflammation
- Support neuronal membrane integrity
- May enhance chemotherapy sensitivity
- Help counter cancer-related cachexia (muscle loss)
Glioma cells demonstrate altered lipid metabolism, and preclinical research suggests DHA may increase tumor cell susceptibility to oxidative stress.
Research
Colas S, et al. showed omega-3 fatty acids influence glioma cell signaling pathways.
https://pubmed.ncbi.nlm.nih.gov/20197462/
Murphy RA, et al. demonstrated omega-3 supplementation can help preserve lean body mass in cancer patients.
https://pubmed.ncbi.nlm.nih.gov/22584984/
Practical Use
- 1–3 grams combined EPA/DHA daily (medical supervision recommended)
- Prefer high-quality, third-party tested fish oil
2. Curcumin (Turmeric Extract)
Why It Matters
Curcumin has demonstrated:
- Anti-inflammatory activity
- Inhibition of NF-κB and STAT3 pathways
- Anti-angiogenic effects
- Potential radiosensitizing properties
Glioblastoma is characterized by aggressive inflammatory and growth signaling. Curcumin targets multiple pathways simultaneously.
Research
Klinger NV, Mittal S. Curcumin as a therapeutic agent for glioblastoma.
https://pubmed.ncbi.nlm.nih.gov/26774776/
Perry MC, et al. demonstrated curcumin’s anti-proliferative effects in glioma models.
https://pubmed.ncbi.nlm.nih.gov/15897582/
Considerations
- Poor oral bioavailability; enhanced formulations (liposomal, phytosome, or with piperine) may improve absorption.
- Typical integrative doses: 1–4 grams/day (under supervision).
3. Melatonin
Why It Matters
Melatonin is more than a sleep hormone. It has:
- Antioxidant activity
- Immune-modulating properties
- Potential anti-proliferative effects in glioma cells
- Evidence of improving survival when combined with radiation in small trials
Research
Lissoni P, et al. reported improved 1-year survival in glioblastoma patients receiving melatonin + radiation vs radiation alone.
https://pubmed.ncbi.nlm.nih.gov/8777138/
Sánchez-Hidalgo M, et al. reviewed melatonin’s anti-tumor mechanisms in glioma.
https://pubmed.ncbi.nlm.nih.gov/23220573/
Practical Use
- Common integrative dosing: 3–20 mg nightly
- Also improves sleep, which supports immune regulation and recovery
4. Medicinal Mushrooms (Turkey Tail, Reishi, Maitake)
Why They Matter
Medicinal mushrooms contain:
- Beta-glucans
- Polysaccharopeptides
- Immune-modulating compounds
They may:
- Enhance NK cell activity
- Support immune resilience during chemotherapy
- Improve quality of life
Turkey Tail (PSK/PSP extracts) has the strongest human oncology evidence overall (though not specific to glioblastoma).
Research
Standish LJ, et al. reported immune enhancement with Trametes versicolor (Turkey Tail) in cancer patients.
https://pubmed.ncbi.nlm.nih.gov/23035793/
Wasser SP. Review of medicinal mushrooms in oncology.
https://pubmed.ncbi.nlm.nih.gov/20635398/
Considerations
- Choose standardized extracts
- Avoid low-quality powdered blends without beta-glucan testing
5. Vitamin D
Brain tumor patients frequently have low vitamin D levels.
Vitamin D may:
- Influence cell differentiation
- Support immune regulation
- Impact glioma cell proliferation
Research:
Trouillas P, et al. Vitamin D and glioma growth inhibition.
https://pubmed.ncbi.nlm.nih.gov/18538944/
Testing 25-OH vitamin D blood levels and correcting deficiency is reasonable and safe.
6. Boswellia Serrata (Frankincense)
Particularly interesting in brain tumor patients with radiation-related edema.
Boswellia has been shown to:
- Reduce cerebral edema
- Decrease steroid requirements
Kirste S, et al. demonstrated reduced brain edema in patients receiving Boswellia during radiation.
https://pubmed.ncbi.nlm.nih.gov/21287538/
This may help reduce long-term corticosteroid side effects.
Important Safety Notes
- Supplements can interact with chemotherapy and radiation.
- High-dose antioxidants during radiation remain controversial.
- Always involve your oncology team.
- Prioritize quality, third-party tested products.
Summary of Evidence Strength
| Supplement | Mechanistic Evidence | Human Data | Best Supported Use |
|---|---|---|---|
| Omega-3s | Strong | Moderate | Anti-inflammatory, muscle preservation |
| Curcumin | Strong | Early clinical | Anti-proliferative support |
| Melatonin | Strong | Small clinical trials | Survival + sleep |
| Mushrooms | Moderate | Immune support trials | Immune resilience |
| Vitamin D | Moderate | Observational | Correct deficiency |
| Boswellia | Moderate | Radiation edema | Steroid reduction |
Support, Side Effects & Survivorship
Treatment side effects can include fatigue, cognitive changes, emotional distress, and physical limitations. Supportive care—nutrition, physical therapy, psychological counseling, and symptom management—can improve quality of life during and after treatment. Involve a multidisciplinary care team to address these aspects comprehensively.
Questions to Ask Your Doctor
Here are key questions that can help guide your care and treatment plan:
- What type and grade of brain tumor do I have?
- What treatments are recommended and why?
- What is the prognosis for my tumor type?
- What clinical trials are available?
- What supportive care services should I plan for?
Final Thoughts
Brain cancer presents unique challenges due to its location and potential impact on neurological function. Early diagnosis, expert multidisciplinary care, and evidence-based treatment strategies can significantly influence outcomes. While survival rates vary by tumor type and grade, advances in imaging, surgery, radiation therapy, and systemic treatments continue to improve the outlook for many patients. Continued research and clinical trial participation remain essential to further progress in this complex field.
Brain Cancer – Need To Know Brain Cancer – Need To Know Brain Cancer – Need To Know Brain Cancer – Need To Know
Brain Cancer – Need To Know